DOI: 10.12890/2022_003463

The Diagnostic and Treatment Challenges of Concomitant Mantle Cell Lymphoma and IgM Myeloma

Authors

  • Dhairya Gor Internal Medicine Department, Jersey Shore Medical Center, Neptune, NJ, USA
  • Rohan Mehta Hematology Oncology Department, Jersey Shore Medical Center, Neptune, NJ, USA
  • David Greenberg Hematology Oncology Department, Jersey Shore Medical Center, Neptune, NJ, USA
  • Evgeniya Angelova Pathology Department, Jersey Shore Medical Center, Neptune, NJ, USA

dhairya.gor@hmhn.org

Keywords

IgM multiple myeloma, mantle cell lymphoma, CAR T-cell therapy

Abstract

It is rare for IgM multiple myeloma (MM) and mantle cell lymphoma (MCL) to coexist. Furthermore, it is challenging to demonstrate if there are two distinct types of neoplasia or if plasma cell differentiation of MCL is present. We discuss the case of a patient concomitantly diagnosed with MCL and IgM MM, and the subsequent diagnostic and management difficulties, and the positive treatment outcome.

View the entire article

Downloads

References

  1. Sikuyayenga MJ, Reeder CB, Mikhael JR. New diagnosis of multiple myeloma in a patient with mantle cell lymphoma: shared genetic factors or simple coincidence? Leuk Res Rep 2012;1(1):7. doi:10.1016/J.LRR.2012.09.003
  2. Young KH, Chan WC, Fu K, Iqbal J, Sanger WG, Ratashak A, et al. Mantle cell lymphoma with plasma cell differentiation.Am J Surg Pathol 2006;30(8):954–961. doi:10.1097/00000478-200608000-00004
  3. Thieblemont C, Nasser V, Felman P, Leroy K, Gazzo S, Callet-Bauchu E, et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 2004;103(7):2727–2737. doi:10.1182/blood-2003-06-2160
  4. Visco C, Hoeller S, Malik JT, Xu-Monette ZY, Wiggins ML, Liu J, et al. Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component. Am J Surg Pathol 2011;35(2):177–189. doi:10.1097/PAS.0B013E3182049A9C
  5. Hummel M, Tamaru JI, Kalvelage B, Stein H. Mantle cell (previously centrocytic) lymphomas express V(H) genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994;84(2):403–407. doi:10.1182/blood.v84.2.403.403
  6. Gradowski JF, Jaffe ES, Warnke RA, Pittaluga S, Surti U, Gole LA, et al. Follicular lymphomas with plasmacytic differentiation include two subtypes. Mod Pathol 2010;23(1):71–79. doi:10.1038/modpathol.2009.146
  7. Keith TA, Cousar JB, Glick AD, Vogler LB, Collins RD. Plasmacytic differentiation in follicular center cell (FCC) lymphomas. Am J Clin Pathol 1985;84(3):283–290. doi:10.1093/ajcp/84.3.283
  8. Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, Maestre L, Sanchez-Verde L, Roncador G, et al. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica 2010;95(8):1342–1349. doi:10.3324/haematol.2009.016113
  9. Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 2009;23(12):2210–2221. doi:10.1038/leu.2009.174
  10. Maddocks K. Update on mantle cell lymphoma. Blood 2018;132(16):1647–1656. doi:10.1182/BLOOD-2018-03-791392
  11. Jain P, Wang M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol 2019;94(6):710–725. doi:10.1002/AJH.25487
  12. Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB, et al. TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood 2017;130(17):1903–1910. doi:10.1182/blood-2017-04-779736
  13. Narkhede M, Mehta A, Ansell SM, Goyal G. CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges. Ann Transl Med 2021;9(12):1036–1036. doi:10.21037/atm-20-5546

Published

2022-07-07

Issue

Vol. 9 No. 7 (2022)

How to Cite

1.
Gor D, Mehta R, Greenberg D, Angelova E. The Diagnostic and Treatment Challenges of Concomitant Mantle Cell Lymphoma and IgM Myeloma. EJCRIM [Internet]. 2022 Jul. 7 [cited 2026 Nov. 3];9(7). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3463

Most read articles by the same author(s)